Canada markets closed

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
8.28-0.05 (-0.60%)
At close: 04:00PM EDT
8.39 +0.11 (+1.33%)
After hours: 05:38PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 289.88M
Enterprise Value 137.93M
Trailing P/E 0.77
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)411.22
Price/Book (mrq)1.97
Enterprise Value/Revenue 677.37
Enterprise Value/EBITDA -1.10

Trading Information

Stock Price History

Beta (5Y Monthly) 0.47
52-Week Change 3-57.06%
S&P500 52-Week Change 322.38%
52 Week High 327.35
52 Week Low 36.86
50-Day Moving Average 38.47
200-Day Moving Average 316.47

Share Statistics

Avg Vol (3 month) 31.42M
Avg Vol (10 day) 3627.26k
Shares Outstanding 534.8M
Implied Shares Outstanding 635.01M
Float 827.51M
% Held by Insiders 11.85%
% Held by Institutions 1102.56%
Shares Short (Apr 15, 2024) 43.18M
Short Ratio (Apr 15, 2024) 43.47
Short % of Float (Apr 15, 2024) 412.31%
Short % of Shares Outstanding (Apr 15, 2024) 49.15%
Shares Short (prior month Mar 15, 2024) 43.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.13%
Return on Equity (ttm)-59.56%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -125.85M
Net Income Avi to Common (ttm)-116.8M
Diluted EPS (ttm)-3.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)158.86M
Total Cash Per Share (mrq)4.57
Total Debt (mrq)6.91M
Total Debt/Equity (mrq)4.70%
Current Ratio (mrq)7.41
Book Value Per Share (mrq)4.27

Cash Flow Statement

Operating Cash Flow (ttm)-97.05M
Levered Free Cash Flow (ttm)-54.19M